%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
2013-10-23T20:39:38+03:00
2013-10-23T20:39:38+03:00
2013-10-23T20:39:38+03:00
application/pdf
bs-0876R-A488
uuid:fc2e2c25-e834-4b2a-a7a4-b8c970f7dcbe
uuid:cd7e2c37-598d-440b-9fbe-aef474e7cdca
Acrobat Web Capture 9.0
endstream
endobj
5 0 obj
<>
endobj
6 0 obj
<>
endobj
3 0 obj
<>
endobj
7 0 obj
<>
endobj
11 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC/ImageI]/XObject<>>>/Type/Page>>
endobj
12 0 obj
[32 0 R]
endobj
13 0 obj
<>stream
/CS0 cs 1 scn
10 815.82 574.5 -729.148 re
f
BT
0.2 scn
/TT0 1 Tf
6.5807 0 0 6.5807 21.1873 767.7801 Tm
(www.biossusa.com)Tj
0 -1.5 TD
(support@biossusa.com)Tj
-0.012 Tw T*
[(800.501.7654)-34( )1([DOMESTIC])]TJ
T*
[(+1.781.569.5821)-57( )1([INTERNATIONAL])]TJ
ET
q
/GS0 gs
140.170105 0 0 -78.9690704 444.3299103 810.5550232 cm
/Im0 Do
Q
BT
0 scn
/TT1 1 Tf
0 Tw 9.2131 0 0 9.2131 21.1873 716.4502 Tm
[(bs)-67(-)-69(0876R)-12(-)-69(A488)]TJ
/TT0 1 Tf
-0.04 Tw 7.2388 0 0 7.2388 22.5034 659.8557 Tm
[(Conjugated)-58( Primary)-1( Antibodies)]TJ
/TT1 1 Tf
0 Tw 0 -1.909 TD
(Background:)Tj
/TT0 1 Tf
-0.04 Tw 0 -1.455 TD
[(AKT,)-16( also)-75( known)-10( as)-29( protein)-79( kinase)-36( B)-47( \(PKB\),)-21( is)-52( a)-20( 57)-90( kDa)-26( serine/threonine)-54( protein)-79( kinase.)-6( There)-82( are)-44( three)]TJ
T*
[(mammalian)-71( isoforms)-2( of)-48( Akt:)-32( AKT1)-46( \(PKB)-71( alpha\),)-15( AKT2)-46( \(PKB)-71( beta\))-43( and AKT3)-46( \(PKB)-71( gamma\))-61( with)-46( AKT2)-46( and AKT3)]TJ
0 -1.455 TD
[(being)-35( approximately)-63( 82%)-22( identical)-83( with)-46( the)-36( AKT1)-46( isoform.)-54( Each)-77( isoform)-85( has)-16( a)-20( pleckstrin)-79( homology)-57( \(PH\)domain,)]TJ
0 -1.455 TD
[(a)-20( kinase)-36( domain)-25( and a)-20( carboxy)-19( terminal)-35( regulatory)-59( domain.)-85( AKT)-46( was)-14( originally)-47( cloned)-39( from)-30( the)-36( retrovirus)-59( AKT8,)]TJ
0 -1.455 TD
[(and is)-52( a)-20( key)-23( regulator)-12( of)-48( many)-33( signal)-5( transduction)-86( pathways.)-61( Its)-29( tight)-83( control)-63( over)-73( cell)-9( proliferation)-57( and cell)]TJ
0 -1.455 TD
[(viability)-40( are)-44( manifold;)-33( overexpression)-27( or)-6( inappropriate)-61( activation)-37( of)-48( AKT)-46( has)-16( been)-19( seen)-35( in)-31( many)-33( types)-7( of)-48( cancer.)]TJ
0 -1.455 TD
[(AKT)-46( mediates)-21( many)-34( of)-48( the)-37( downstream)-27( events)-21( of)-48( phosphatidylinositol)-37( 3)-90( kinase)-36( \(a)-1( lipid)-25( kinase)-36( activated)-15( by)-40( growth)]TJ
0 -1.455 TD
[(factors,)-74( cytokines)-89( and insulin\).)-52( PI3)-75( kinase)-36( recruits)-90( AKT)-46( to)-32( the)-37( membrane,)-60( where)-15( it)-73( is)-52( activated)-15( by)-40( PDK1)]TJ
T*
[(phosphorylation.)-31( Once)-20( phosphorylated,)-9( AKT)-46( dissociates)-80( from)-30( the)-36( membrane)-90( and phosphorylates)-55( targets)-13( in)-31( the)]TJ
0 -1.455 TD
[(cytoplasm)-25( and the)-36( cell)-10( nucleus.)]TJ
/TT1 1 Tf
0 Tw 0 -1.909 TD
(Purification:)Tj
/TT0 1 Tf
-0.04 Tw 6.727 -0.091 Td
[(Was)-36( purified)-38( by)-40( Protein)-81( A)-36( and peptide)-90( affinity)-82( chromatography.)]TJ
/TT1 1 Tf
-0.02 Tw -6.727 -2 Td
[(Modification)-47( Site:)]TJ
/TT0 1 Tf
0 Tw 0 -1.636 TD
(Ser473)Tj
/TT1 1 Tf
0 -1.909 TD
(Storage:)Tj
/TT0 1 Tf
-0.04 Tw 0 -1.455 TD
[(Aqueous)-34( buffered)-15( solution)-14( containing)-88( 100ug/ml)-73( BSA,)-42( 50%)-22( glycerol)-55( and less)-80( than)-25( 0.09%)-82( sodium)-13( azide.)-56( Store)-44( at)-50( -)]TJ
0 -1.455 TD
[(20\260C)-18( for)-52( 12)-90( months.)-54( Protect)-73( from)-30( light.)-67( [Product)-75( without)-66( BSA)-72( and/or)-79( sodium)-13( azide)-87( is)-52( available)-70( for)-52( special)-31( order.])]TJ
/TT1 1 Tf
0 Tw 0 -1.909 TD
(Reconstitution:)Tj
/TT0 1 Tf
-0.04 Tw 0 -1.455 TD
[(If)-36( the)-36( antibody)-25( is)-52( in)-31( liquid)-13( form,)-91( no)-81( reconstitution)-78( needed.)]TJ
0 -2.909 TD
[(Reconstitution)-90( is)-52( only)-81( required)-62( for)-52( the)-37( lyophilized)-45( antibody.)-86( Please)-15( refer)-92( to)-32( the)-36( reconstitution)-78( instruction)-26( card)-10( in)]TJ
0 -1.455 TD
[(the)-37( package.)]TJ
/TT1 1 Tf
0 Tw 53.545 39 Td
(Size:)Tj
/TT0 1 Tf
3 -0.091 Td
(100ul)Tj
/TT1 1 Tf
-3 -2.818 Td
(Concentration:)Tj
/TT0 1 Tf
8.091 -0.091 Td
(1ug/uL)Tj
/TT1 1 Tf
-8.091 -2.818 Td
(Host:)Tj
/TT0 1 Tf
3.273 -0.091 Td
(Rabbit)Tj
/TT1 1 Tf
-3.273 -1.909 Td
(Reactivities:)Tj
0.2 scn
/TT0 1 Tf
6.5807 0 0 6.5807 410.11 624.9777 Tm
(Human,Mouse,Rat,Chicken,Dog,Pig,Bovine,Rabbit,Sheep,)Tj
0 scn
/TT1 1 Tf
7.2388 0 0 7.2388 410.11 611.1581 Tm
(Application:)Tj
ET
q
10 36 575 780 re
W n
q 1 0 0 1 419.9811 593.7191 cm
0 0 m
0 1.316 -1.974 1.316 -1.974 0 c
-1.974 -1.316 0 -1.316 0 0 c
f
Q
Q
BT
/TT0 1 Tf
7.2388 0 0 7.2388 426.5619 592.0739 Tm
[(FCM\(1:100)-4(-)-1(500\))]TJ
ET
q
10 36 575 780 re
W n
q 1 0 0 1 419.9811 583.1899 cm
0 0 m
0 1.316 -1.974 1.316 -1.974 0 c
-1.974 -1.316 0 -1.316 0 0 c
f
Q
Q
BT
/TT0 1 Tf
7.2388 0 0 7.2388 426.5619 581.5447 Tm
[(IF\(1:100)-3(-)-1(500\))]TJ
ET
q
10 36 575 780 re
W n
q 1 0 0 1 419.9811 572.6606 cm
0 0 m
0 1.316 -1.974 1.316 -1.974 0 c
-1.974 -1.316 0 -1.316 0 0 c
f
Q
Q
BT
/TT0 1 Tf
-0.04 Tw 7.2388 0 0 7.2388 426.5619 571.0155 Tm
[(Not)-1( yet)-6( tested)-8( in)-31( other)-43( applications.)-57( Optimal)]TJ
0 -1.455 TD
[(working)-62( dilutions)-48( must)-4( be)-12( determined)-86( by)-40( the)]TJ
0 -1.455 TD
[(end)-90( user.)]TJ
/TT1 1 Tf
-0.02 Tw -2.273 -3.818 Td
[(Antibody)-48( Type:)]TJ
/TT0 1 Tf
0 Tw 8.182 -0.091 Td
(Polyclonal)Tj
/TT1 1 Tf
-8.182 -1.909 Td
(Isotype:)Tj
0.2 scn
/TT0 1 Tf
6.5807 0 0 6.5807 452.8849 507.8402 Tm
(IgG)Tj
0 scn
/TT1 1 Tf
-0.02 Tw 7.2388 0 0 7.2388 410.11 494.0206 Tm
[(Molecular)-1( Weight:)]TJ
0.2 scn
/TT0 1 Tf
0 Tw 6.5807 0 0 6.5807 488.421 494.0206 Tm
(56kDa)Tj
0 scn
/TT1 1 Tf
7.2388 0 0 7.2388 410.11 480.201 Tm
(Note:)Tj
/TT0 1 Tf
0.021 Tw 5.9227 0 0 5.9227 410.11 453.2199 Tm
[(For)-20( )1(research)-16( )1(use)-25( )1(only.)-91( )1(CAUTION:)-13( )1(Not)-12( )1(for)-1( )1(human)-72( )1(or)-97( )1(animal)]TJ
0 -1.333 TD
[(therapeutic)-36( )1(or)-97( )1(diagnostic)-13( )1(use.)]TJ
ET
q
/GS0 gs
559.3642731 0 0 -0.6580811 19.8711395 707.8952179 cm
/Im1 Do
Q
BT
/TT0 1 Tf
0 Tw 10.5292 0 0 10.5292 15.2646 88.646 Tm
( )Tj
ET
q
10 36 575 780 re
W n
/CS3 cs 0.302 0.306 0.333 scn
q 1 0 0 1 13.2904 692.7595 cm
0 0 m
0 1.755 -2.632 1.755 -2.632 0 c
-2.632 -1.755 0 -1.755 0 0 c
f
Q
Q
BT
/CS3 cs 0.302 0.306 0.333 scn
/TT1 1 Tf
-0.007 Tw 9.2131 0 0 9.2131 22.5034 690.1272 Tm
[(Rabbit)-50( Anti)-28(-)-69(phospho)-70(-)-69(AKT)-7( \(Ser473\))-20( Polyclonal)-4( Antibody,)-47( Alexa)-2( Fluor)-69( 488)]TJ
0 Tw 0 -1.143 TD
(conjugated)Tj
ET
q
/GS0 gs
98.7113495 0 0 -74.3625488 19.2130585 392.6769867 cm
/Im2 Do
Q
BT
/CS0 cs 0 scn
/TT0 1 Tf
10.5292 0 0 10.5292 19.2131 309.1014 Tm
( )Tj
ET
q
/GS0 gs
98.7113495 0 0 -74.3625488 145.5635834 392.6769867 cm
/Im3 Do
Q
BT
/TT0 1 Tf
10.5292 0 0 10.5292 145.5636 309.1014 Tm
( )Tj
12 0 Td
( )Tj
-24 -2.25 Td
( )Tj
12 0 Td
( )Tj
12 0 Td
( )Tj
-24 -2.25 Td
( )Tj
12 0 Td
( )Tj
12 0 Td
( )Tj
-0.04 Tw 7.2388 0 0 7.2388 20.5292 230.1323 Tm
[(For)-31( full)-30( size)-82( images)-63( and description)-26( please)-13( click)-31( )]TJ
/CS3 cs 0 0.6 0.8 scn
0 Tw 6.5807 0 0 6.5807 173.2028 230.1323 Tm
(HERE)Tj
/CS0 cs 0 scn
7.2388 0 0 7.2388 189.6546 230.1323 Tm
(.)Tj
ET
q
/GS0 gs
0.6580811 0 0 -592.2680511 397.6065521 707.2371216 cm
/Im4 Do
Q
q
/GS0 gs
5.9226837 0 0 -40.1426086 578.5773468 126.8144379 cm
/Im5 Do
Q
endstream
endobj
14 0 obj
<>
endobj
15 0 obj
(`U¤mEF-)
endobj
26 0 obj
<>stream
Hy\E323#3
P̴,HLEK"+E+2VTD%EH# }wfwfvvc_3?{feޝ@HHHHHH*豘V]
zן)@-9.q2BÇEڂ8g "2vn>u2]/Yz \S@ 7.M&p?o9v 0'rKś-;(Au.J%% %&˶0>6`TxOzzo(VDY*AZp ËgAs^.㮌+2Ȱ$E['FC:OMCIVVDD3}`u߈buߨɴ4қԭV^V0XF ϓ@i|Y|.?i'3}Ŵ+ޘaa:
3g},F"kNɳՕx57,H)X7*v/Mո+(fWr=WӃJcߓtG16sPt:t"9G
if
3do\ˢ|c:1&<ЭWnPdq0IRgu~惘n9BWV2T6~}rs4h-D.sgV/n3;q@hThI*jTJqJK2c!QT7;60
5NoJݻ'rBP%ȍ4
P(/CJC1
9eڴ}5S{"wty@P5e*Zg~?S(Sɗ,ʽv 2[̋t_Z\d&}/2YϹO&y#
?P>,0P-
asds[U꼩\=T~)S>B,gk$7+j0?60<&uźg
A]_@en%Mȝ~5PSu$^2s0RSPw L9٦n9$vڣ=f#g 7,Oa
:ܾ.4+H!=MvF(G|YU
ITR)>@✧*[j5KoB{Kp,`姙$JO궒jvż@r3`w\A%jSx+>m;5ا@._1:T#q]wrTC8r:lU4P}~Y]XwJ~b:YQϗLP-X_ֻа2$ݥC=~P]VҘLhu?S'\C:7"4dD*%9 Ogfe\OLoTy5Qkj.84,: t:_YON3˃:O/r犁3t!Psbty{aETu7nMѶ f+^Y6zHic?R%+C,γL =ZJ1H+,x^
I!u2{5x_@LI6[w5LN5:xXoEgf9tu=yùw=aґza*҃K`驪eP/y*sσn3N{ME\8g: *fz#W??L